Stanford infectious disease experts devise a way to use finger-prick blood samples from small groups to detect typhoid in large populations.
A Stanford pediatric infectious disease expert is highlighted in a new campaign to answer parents' questions about COVID-19 vaccines.
Stanford researchers investigate vaccine hesitancy and show how to better communication about vaccines to encourage acceptance.
A new way to deliver mRNA as a COVID-19 vaccine may avoid side effects and increase customization to prevent infection.
Stanford medical student from Sierra Leone calls for urgent improvements in efforts to protect the people of African nations against COVID-19.
New research shows that 65% of people in the US will be partially vaccinated by July 4 — but for Hispanic and Black people, rates are lower.
With COVID-19 information evolving daily, the Stanford Health Care pharmacy team had to prepare for the unexpected in its vaccine rollout.
Anxious to protect her children, Stanford immunology researcher enrolls her two young children Pfizer’s COVID-19 vaccine clinical trial for kids.
Stanford Medicine researchers have found a new way to stabilize mRNA molecules, something that could boost COVID vaccines.
Stanford University researchers have developed a nanoparticle vaccine that has shown in mouse studies to effectively build coronavirus immunities.
Stanford scientists transformed tonsils into immunology labs in a dish, aiding research to develop vaccines for COVID-19, the flu and other diseases.
In a modeling study, Stanford researchers find that an approach that holds back COVID-19 vaccine doses for later use needlessly delays vaccination for many.
The Pfizer and Moderna COVID-19 vaccines are the first to use the RNA coding molecule to prompt our bodies to fight the virus. Here's how they work.
Stanford Health Care physician Megan Mahoney, MD, describes how conversations with family helped her decide to be among the first to get the COVID-19 vaccine.
Two recent Stanford-led studies show the value of tweaking vaccines to enlist the entire immune system — not just part of it — in preventing HIV infection.
A Stanford microbiologist describes the invigorating, yet sobering race to develop an effective vaccine against COVID-19.